Given that SPC24 was strikingly up-regulated in HCC tissues, it was closely associated with multiple tumor number, tumor size > 5 cm, and the presence of PVTT, we concluded that SPC24 might serve as a novel biomarker to predict prognosis outcome for HCC patients. This evidence concerns the gene SPC24 and hepatocellular carcinoma.